Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Verrica Pharmaceuticals Inc.
Charite University, Berlin, Germany
Indiana University
Yale University
University of Arizona
Avita Medical
NYU Langone Health
Apexigen America, Inc.
Rutgers, The State University of New Jersey
Clinigen, Inc.
Klein Buendel, Inc.
Northwestern University
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
Nektar Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Idera Pharmaceuticals, Inc.
Ludwig Institute for Cancer Research
H. Lee Moffitt Cancer Center and Research Institute
University Hospitals Cleveland Medical Center
Novartis
University of Connecticut
Dynavax Technologies Corporation
University of California, San Francisco
Icahn School of Medicine at Mount Sinai
Pfizer
University of Sao Paulo
University of Rochester
Massachusetts Eye and Ear Infirmary
Weill Medical College of Cornell University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Celldex Therapeutics
National Cancer Institute (NCI)
Novartis
San Diego State University
Stanford University
Arch Therapeutics
Stanford University
AbbVie
Stanford University